Stacy Loretz-Congdon
Analyst
Thanks, Tom, and good morning, everyone. I'd like to start my comments with a brief discussion of our earnings per share. Diluted EPS for the fourth quarter was $1.29 compared to $0.83 last year. Or for those of you who model EPS, excluding LIFO expense, this translates to $1.28 for the quarter compared to $0.90 last year, a 42% improvement. Normalized for unusual and one-time items, LIFO EPS for the quarter was up 32%, driven primarily by the growth in our non-cigarette sales and related margin improvement. For the year, diluted EPS grew 23% to $3.58 compared to $2.91 for 2012. We had guided to a range of $3.35 to $3.45 and beat that expectation due to our LIFO expense coming in lower than expected. As a reminder, our LIFO expense is tied to the Producer Price Index and reflects inflation, or lack thereof, in the various product categories we carry. Excluding LIFO expense, we earned $4.04 this year compared to $3.55 last year, a 13.8% increase. We are pleased to see this fall in between our guidance of $4 to $4.10. Free cash flow per diluted share was $4.52 compared to $4.27 for 2012. Our year-end inventory buildup was approximately $7 million higher than the end of 2012, which roughly translates to about $0.60 of free cash flow per share. More on free cash flow later. For 2014, we are guiding to an EPS range between $3.50 and $3.65, which includes an estimate of $13 million of LIFO expense, $7 million of cigarette price increase, a 39% tax rate and 11.7 million diluted shares outstanding. These 4 key assumptions compared to 2013's results equate to a reduction of approximately $0.48 per share. On a FIFO basis, we are guiding to an EPS range of $4.15 to $4.30, compressed by $0.26 related to the changes in our CPI, tax rate and outstanding share assumptions. Had we used the same CPI, tax rate and LIFO expense as in 2013, our FIFO EPS guidance for 2014 would have been a range of $4.41 to $4.56 compared to $4.04 this year. This represents an adjusted growth rate of 9% to nearly 13% over 2013 results. However, since several of these key assumptions are so unpredictable, we felt conservative estimates at this time was the most appropriate approach to our guidance. Our expected free cash flow for 2014 should fall within a range of $4.70 to $5.10, assuming we spend $30 million in CapEx and assuming the buildup of inventory levels at year end are similar to this year. I think it is worth mentioning that we generated sufficient excess cash in 2013 to pay out dividends of $7.1 million or $0.61 per share spread over 3 dividend payments, following the accelerated Q1 dividend paid on December 31, 2012. We also repurchased about 7 million of our shares, offsetting all of our 2013 dilutive incentive shares, while continuing to invest in the business. Our financial condition continues to be very healthy. And now, moving onto the fourth quarter results. Sales increased 13.8% in Q4 from $2.2 billion last year to $2.5 billion this year. Cigarette sales increased 11.8%, and our non-cigarette sales increased 18.2%. We had one extra selling day during the fourth quarter compared to the same period last year, representing approximately 2% of our growth. Cigarette sales increased 11.8% for the quarter on a 10% increase in carton sales. This increase was driven primarily by the additional cartons sold by our Carolina division and by market share wins which offset a 4.3% decline in same-store carton sales. More importantly, our non-cigarette categories increased over $123 million or 18.2%, including Carolina's contributions. Excluding Carolina, we still saw 13% growth across multiple non-cigarette categories led by food, which increased 15.3%. Same-store sales grew a healthy 7.3%, and market share wins contributed to the acceleration and the growth rates of our non-cigarette sales. We believe this success is being driven by our core strategies, Fresh, VCI and FMI. Gross profit increased $21.4 million to $143.3 million, an increase of 17.6% for the fourth quarter of 2013. Remaining gross profit increased $19.2 million or 16% to $139.1 million. Gross profit margins for the quarter were up 18 basis points, and remaining gross profit margins, which excludes LIFO and cigarette holding gains, increased 11 basis points. Excluding the compressing effect of Carolina and Turkey Hill, which we started servicing during the second quarter, remaining gross profits were up 23 basis points. Cigarette remaining gross profit increased 5.1% or approximately $1.9 million, benefiting from our new Carolina division and new customers gained during 2013. Non-cigarette remaining gross profit increased 20.8% or $17.2 million for Q4 2013. About 1/3 of this growth came from our Carolina division, with the remainder driven largely by our focus on selling higher-margin products to our existing and new customers. In total, our non-cigarette margins as a percentage of sales increased 27 basis points, all in. Diverting in promotional activity during the fourth quarter assisted in our -- in driving 16 basis point improvements in our candy and snack categories, and our e-cigarette sales growth of 117% bolstered general merchandise margins. Moving on, operating expenses were $119.5 million in the fourth quarter this year compared to $105.6 million for the same period last year, a 13.2% increase, which supported our sales growth, specifically our non-cigarette categories, which increased 18.2%. Almost half of the increase in operating expenses was generated by our new Carolina division. As a percent of sales, operating expenses decreased 2 basis points. Warehouse and delivery expenses increased $12.5 million or approximately 19.4% to $77.2 million during the fourth quarter, including one extra work day. Excluding our newest division, warehouse and delivery expenses increased 16 basis points as a percentage of sales, 4 basis points of which were driven by higher workers' compensation cost. On the surface, it appears we didn't leverage warehouse and delivery. However, as we sell more of the non-cigarette categories, 2 things are happening: first, cubic feet are increasing 13.3% during the quarter, meaning more product is being handled in the warehouse; and second, the non-cigarette products we are shipping have lower selling price points than cigarettes, which puts upward pressure on the operating expenses as a percent of sales. Our cost per cubic foot of products sold actually decreased during the quarter on a comparative basis, and the impact of selling more non-cigarettes than the higher-priced cigarette categories increased warehouse and delivery as a percentage of sales by approximately 12 basis points. SG&A grew only $1.3 million or 3.2% during the fourth quarter, and as a percentage of sales, decreased 17 basis points. Lower stock comp resulting from canceled performance shares, the pension curtailment gain and lower legal expenses this quarter versus last year represented approximately 75% of this improvement. Moving further down the income statement, our effective tax rate for the quarter was 35.3% versus 38.2% for the fourth quarter in 2012. For the year, our effective tax rate was 37% compared to 38.8% last year. The decrease for the year was driven primarily by a higher portion of our earnings being generated in states with lower tax rates and favorable adjustments to prior years' estimates. We are also seeing some weakening in the Canadian dollar, which reduced year-to-date EPS by approximately $0.04 a share and reduced Canada's contribution to sales by about $35 million for the year. Moving to cash flows. Cash generated from operations before working capital changes was $88.5 million for 2013 compared to $80.6 million last year, a 10% increase. Changes in working capital, which measures 2 single points in time, resulted in a use of cash in 2013 of $29 million compared to a use of $9 million in 2012. The largest contributor to this increase was cash used for the purpose of buying inventory and related prepayments for inventory. Free cash flow, which we measure as adjusted EBITDA, plus or minus changes in working capital, less CapEx, cash taxes and cash interest, was slightly over $52 million for 2013. However, at the end of the year, we did have a temporary spike in the use of cash for inventory, which was about $7 million more this year compared to the end of 2012. All in all, our free cash flow is at the mid-range of our expectations if you add back the $7 million in short-term inventory investment. For 2014, we expect free cash flow to be between $55 million and $60 million, depending, of course, on any unusual year-end activity. As many of you know, our return on net assets standard is 20%, which means we focus on meeting or approaching that standard when making our investment decisions. The net assets we monitor include inventory, receivables and fixed assets, less accounts payables, tobacco payables and accrued liabilities. All major components to our working capital management and monitored on a daily basis. For 2013, our RONA was just above 18%. We constantly evaluate our options when investing our capital. However, to be clear, we may, from time to time, invest at slightly lower returns if an investment position us for future growth or contributes positively to free cash flow. Our weighted average cost of capital is roughly 9% to 10%. So depending on the risk premium assigned to a particular project, we feel good about making investments that exceed that minimum threshold that allow us to strive for our 20% standard. Average debt for the year was $35.3 million compared to $26.3 million in 2012. Average internment working capital swings were approximately $49 million for the year, with our peak debt position at about $112 million late in May when we started buying inventory in anticipation of a cigarette price increase which occurred in June. Our current ratio continues to be strong at 2:1, and our average monthly cash conversion cycle was approximately 13.8 days in 2013 compared to 14.3 days last year. We include accounts payable and tobacco taxes payable in our cash conversion cycle due to the significant role both play in our working capital management. Our capital allocation decisions support our key strategies and focus on ensuring we have sufficient capital to fund acquisitions, CapEx, opportunistic inventory buys, dividends and share repurchases. Last year, we purchased J.T. Davenport in December, and to date, have paid $37.9 million, including the post-closing adjustments paid this year. We have approximately $3 million still held back for various indemnifications and expect this amount to be settled over the next 3 years. In 2013, we incurred approximately $1.6 million of integration costs to bring the Carolina division onto our system and also spent another $1.2 million for expansion activities related to on-boarding new, large customers and prospective market share gains. For CapEx, we spent $18 million in 2013, less than we anticipated, due primarily to the delay of certain projects as we were busy on-boarding new business and other delays in the order or payment cycles for certain equipment. Over 5 million of our 2013 planned projects are carrying over into 2014. We expect to spend approximately $30 million during this year, including carryover amounts. To summarize, we had a very strong quarter stemming from strong sales and margin growth in our non-cigarette categories, contributing to solid earnings for the year. We are cautiously optimistic as we move into 2014, but remind our investors that Q1 is historically the softest quarter of the year. That being said, we are pleased with our growth trajectory and continue to generate substantial free cash flow and are carrying very modest debt. We look forward to 2014 with optimism, knowing that our core strategies continue to help build a sustainable, competitive advantage. And with that, I would like to thank all of our employees, our vendors, our customers and you, our shareholders, for your continued support. Operator, you can now open the line for questions.